End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,680 KRW | -1.82% |
|
-2.06% | -30.16% |
2023 | Vaxcell-Bio Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2021 | Vaxcell-Bio Therapeutics Co., Ltd.(KOSDAQ:A323990) added to S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-30.16% | 259M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- A323990 Stock
- News Vaxcell-Bio Therapeutics Co., Ltd.
- Vaxcell-Bio Therapeutics Co., Ltd. has completed an IPO in the amount of KRW 29.5548 billion.